EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Perspective for Drug Discovery Targeting SARS Coronavirus Methyltransferases: Function, Structure and Inhibition

Xin Li iD, Yongcheng Song iD

Journal of Medicinal Chemistry · 2024

DOI: 10.1021/acs.jmedchem.4c01749 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Medicinal Chemistry, 2024. Verfasst von Xin Li und 1 weiteren Autor:innen. Hauptthemen laut MEDLINE: Methyltransferases, Antiviral Agents, Drug Discovery, SARS-CoV-2. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 119 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIAID NIH HHS, NIH.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Severe acute respiratory syndrome-associated coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19), is highly contagious and caused a catastrophic pandemic. It has infected billions of people worldwide with >6 million deaths. With expedited development of effective vaccines and antiviral drugs, there have been significantly reduced SARS-CoV-2 infections and associated mortalities and morbidities. The virus is closely related to SARS-CoV, which emerged in 2003 and infected several thousand people with a higher mortality rate of ∼10%. Because of continued viral evolution and drug-induced resistance, as well as the possibility of a new coronavirus in the future, studies for new therapies are needed. The viral methyltransferases play critical roles in SARS coronavirus replication and are therefore promising drug targets. This review summarizes the function, structure and inhibition of methyltransferases of SARS-CoV-2 and SARS-CoV. Challenges and perspectives of targeting the viral methyltransferases to treat viral infections are discussed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MethyltransferasesAntiviral AgentsDrug DiscoverySARS-CoV-2Severe acute respiratory syndrome-related coronavirusHumansCOVID-19 Drug TreatmentCOVID-19Enzyme InhibitorsViral Nonstructural Proteins

Substanzen

MethyltransferasesAntiviral AgentsEnzyme InhibitorsViral Nonstructural Proteins

Autor:innen und Institutionen

ORCID-Profile: Xin Li, Yongcheng Song

Förderung

  • NCI NIH HHS
  • NIAID NIH HHS
  • NIH
  • National Cancer Institute
  • National Institute of Allergy and Infectious Diseases
  • Cancer Prevention and Research Institute of Texas

Zitieren

APA

Li, X., & Song, Y. (2024). Perspective for Drug Discovery Targeting SARS Coronavirus Methyltransferases: Function, Structure and Inhibition. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.4c01749

Vancouver

Li X, Song Y. Perspective for Drug Discovery Targeting SARS Coronavirus Methyltransferases: Function, Structure and Inhibition. Journal of Medicinal Chemistry. 2024. doi:10.1021/acs.jmedchem.4c01749

BibTeX
@article{Li2024,
  author = {Li, Xin and Song, Yongcheng},
  title = {Perspective for Drug Discovery Targeting SARS Coronavirus Methyltransferases: Function, Structure and Inhibition},
  journal = {Journal of Medicinal Chemistry},
  year = {2024},
  doi = {10.1021/acs.jmedchem.4c01749}
}
Kostenlos starten →